
Sign up to save your podcasts
Or


At the 2023 San Antonio Breast Cancer Symposium, Dr. Hatem Azim presented a new analysis of information from the POSITIVE trial, which found that younger women diagnosed with early-stage, hormone receptor-positive breast cancer could safely pause hormonal therapy to try to become pregnant. His new analysis looked at whether the women could use fertility preservation and assisted reproductive technologies (ART) without increasing the risk of the cancer coming back (recurrence).
Listen to the podcast to hear Dr. Azim discuss:
By Breastcancer.org4.3
4242 ratings
At the 2023 San Antonio Breast Cancer Symposium, Dr. Hatem Azim presented a new analysis of information from the POSITIVE trial, which found that younger women diagnosed with early-stage, hormone receptor-positive breast cancer could safely pause hormonal therapy to try to become pregnant. His new analysis looked at whether the women could use fertility preservation and assisted reproductive technologies (ART) without increasing the risk of the cancer coming back (recurrence).
Listen to the podcast to hear Dr. Azim discuss:

22,033 Listeners

1,093 Listeners

2,038 Listeners

1,693 Listeners

2,627 Listeners

3,522 Listeners

9,254 Listeners

53 Listeners

4,379 Listeners

330 Listeners

376 Listeners

20,393 Listeners

1,187 Listeners

120 Listeners

30 Listeners